News
Read the latest triple negative breast cancer (TNBC) news and updates from The UK Charity for TNBC.
Explore stories on TNBC research, treatment, clinical trials, and policy developments, alongside news about the charity’s work in advocacy, education, awareness, and action for people affected by TNBC.
Bringing the Voice of TNBC to AstraZeneca’s Advocacy Leaders Summit
The UK Charity for TNBC recently attended AstraZeneca’s Advocacy Leaders Summit alongside other UK charities large and small, helping to ensure the voice of the TNBC community was represented in wider discussions around cancer care, collaboration and the Government’s Cancer Plan.
First House of Hope TNBC Meet-Up Brings People Together in Edinburgh
The UK Charity for TNBC joined House of Hope Scotland in Edinburgh for its first dedicated TNBC meet-up, bringing people together to share experiences, connect with others and have open conversations about life after a TNBC diagnosis.
Landmark UK TNBC Symposium brings together clinicians and researchers
The landmark UK TNBC Symposium 2026 will bring together clinicians, researchers and healthcare professionals for a dedicated discussion on progress in triple negative breast cancer treatment, care and research.
The UK Charity for TNBC Partners with The House of Hope and Will Join First Edinburgh TNBC Support Group
The UK Charity for TNBC is proud to partner with The House of Hope Scotland. Founder Robin Woolcock will attend the organisation’s first TNBC support group in Edinburgh on Tuesday 25 August, and people affected by triple negative breast cancer are warmly invited to join.
Our First Ever PAP Meet Up
Members of The UK Charity for TNBC’s Patient Advisory Panel came together in person for the first-ever PAP meet-up in London - an evening filled with connection, shared experiences, support and a strong sense of community.
The UK Charity for TNBC to host first Patient Advisory Panel meet-up
The UK Charity for TNBC is excited to announce the first face-to-face meet-up for existing members of the Patient Advisory Panel (PAP) on Thursday the 2nd of July at Future Dreams House in King’s Cross, London.
Maggie’s 30 Year Celebration
The UK Charity for TNBC would like to congratulate Maggie’s as it celebrates 30 years of supporting people affected by cancer.
What the New National Cancer Plan means for people with triple negative breast cancer
What does the new National Cancer Plan mean for people with triple negative breast cancer (TNBC)? Our latest update explains the potential impact on care and treatment.
Robin Woolcock joins LACE Partners’ podcast to highlight the workplace impact of TNBC
Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins LACE Partners’ podcast to raise awareness of TNBC and spark vital conversations about how workplaces can better support those affected.
The Patient Voice helps guide BioNTech design for UK Drug Trial
The UK Charity for Triple Negative Breast Cancer (TNBC) recently asked our Patient Advisory Panel (PAP) members a series of important questions on behalf of the pharmaceutical company BioNTech. Their answers provided critical information which will now be used by BioNTech to help inform the design of a trial for an investigational drug intended for people with the metastatic form of TNBC.
Charity helps NICE (the National Institute for Health and Care) to recommend new treatment for people with TNBC
New NICE guidance on TNBC treatment reflects input from The UK Charity for TNBC’s Patient Advisory Panel (PAP). Your involvement is helping to shape more effective care for those affected by TNBC.
Report from ESMO Breast 2025
The UK Charity for TNBC attended ESMO Breast 2025 in Munich, presenting a poster, ‘Needs of People with Triple Negative Breast Cancer (TNBC): The Patients Voice’, based on roundtable discussions in partnership with RCNi, produced by Dr Hira Yousef and Professor Chris Twelves.
Make 2nds Count can help find a trial for you!
Make 2nds Count has relaunched its free clinical trials service, helping secondary breast cancer patients, including those with triple negative breast cancer, find suitable trials. This nurse-led support offers expert guidance and tailored searches.
Government Recognises That TNBC Needs A Specific Approach
Recently in parliament, government representatives recognised that a cancer specific approach is needed to meet the challenges in cancer care and to improve outcomes for people living with triple negative breast cancer.
We are looking for more TNBC Champions!
Apply now for the free TNBC Study Day on 21st March 2025 in London. Limited to 25 places, this CPD-certified event is your chance to become a TNBC Nurse Champion. Educate, engage, and lead as the expert in your team. Apply via RCNi today!
Keytruda (Pembroluzimab) Positive Results!
Positive results have been shared by pharmaceutical company MSD from their recent trial with Keytruda, combined with chemotherapy, as a promising treatment for high-risk early-stage triple negative breast cancer patients
The UK Charity for TNBC Becomes NICE Stakeholder
The UK Charity for Triple Negative Breast Cancer is delighted to become a NICE stakeholder, contributing patient perspectives to the development of key breast cancer treatments.
Education Grants for Nurses!
The UK Charity for Triple Negative Breast Cancer is delighted to be announcing a Foundation to provide grants to fund further education for individual breast cancer nurses.
The UK Charity for TNBC Appears on BOPA Podcast
Robin Woolcock, founder of the UK Charity for Triple Negative Breast Cancer, joins Michal Sladkowski on the Let's Talk About SACT podcast. He discusses his experience with TNBC, the motivation behind the charity, and the support available for patients and staff.